Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Sep;80(1):149-53.
doi: 10.1111/j.1476-5381.1983.tb11060.x.

Inhibition by purines of the inotropic action of isoprenaline in rat atria

Inhibition by purines of the inotropic action of isoprenaline in rat atria

P R Hughes et al. Br J Pharmacol. 1983 Sep.

Abstract

The effects of a series of adenosine derivatives were examined on the catecholamine-stimulated electrically-driven rat left atrium in vitro. All the purines tested reduced the positive inotropic action of isoprenaline, 0.1 microM, with the potency order: L-N6-phenlylisopropyladenosine (L-PIA) greater than 5'-N-ethylcarboxamide adenosine (NECA) greater than D-PIA greater than 2-chloroadenosine greater than adenosine. Dipyridamole did not change the IC50 of adenosine. The adenosine deaminase inhibitor, 2'deoxycoformycin, produced a small but nonsignificant shift to the left of the adenosine concentration-response curve. The cardiac depressant effects of these purines were reversed by theophylline and the IC50 values were unchanged in the presence of atropine or in atria taken from reserpine-treated rats. It is concluded that the purine receptor mediating these effects should not be classified on the A1/A2 system. The relationship between functionally characterized purine receptors and those originally defined as modulating adenylate cyclase is discussed.

PubMed Disclaimer

References

    1. J Pharmacol Exp Ther. 1965 May;148:202-14 - PubMed
    1. Br J Pharmacol. 1983 Jan;78(1):207-12 - PubMed
    1. J Physiol. 1981;313:1-35 - PubMed
    1. Pharmacol Ther. 1982;17(3):399-429 - PubMed
    1. J Pharm Pharmacol. 1982 Oct;34(10):664-6 - PubMed

Publication types